Go Pro
→ Bezos… DOOMED (From Paradigm Press) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Humana Inc. stock logo
HUM
Humana
$405.90
+1.2%		$388.11
$163.11
▼
$428.88
$48.15B0.741.04 million shs769,532 shs
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
$36.36
-3.0%		$40.34
$8.30
▼
$47.84
$2.36B2.18578,664 shs460,151 shs
Don't Wait for the OpenAI IPO Cover
Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Humana Inc. stock logo
HUM
Humana
+1.44%+3.36%+12.03%+16.02%+30.01%
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
-3.04%-7.06%-15.22%+17.10%+324.27%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Humana Inc. stock logo
HUM
Humana
$405.90
+1.2%		$388.11
$163.11
▼
$428.88
$48.15B0.741.04 million shs769,532 shs
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
$36.36
-3.0%		$40.34
$8.30
▼
$47.84
$2.36B2.18578,664 shs460,151 shs
Don't Wait for the OpenAI IPO Cover
Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Humana Inc. stock logo
HUM
Humana
+1.44%+3.36%+12.03%+16.02%+30.01%
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
-3.04%-7.06%-15.22%+17.10%+324.27%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Humana Inc. stock logo
HUM
Humana
2.43
Hold$403.91-0.49% Downside
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
2.63
Moderate Buy$48.1432.41% Upside

Current Analyst Ratings Breakdown

Latest FCM, AFRK, KOD, and HUM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/24/2026
Humana Inc. stock logo
HUM
Humana
Wolfe Research logo
Wolfe Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform$450.00
8/17/2026
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$58.00
8/14/2026
Humana Inc. stock logo
HUM
Humana
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C-) ➝ Hold (C)
8/11/2026
Humana Inc. stock logo
HUM
Humana
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
8/10/2026
Humana Inc. stock logo
HUM
Humana
JPMorgan Chase & Co. logo
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$316.00 ➝ $393.00
8/4/2026
Humana Inc. stock logo
HUM
Humana
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeUnderweight ➝ Equal Weight$249.00 ➝ $370.00
8/3/2026
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
JPMorgan Chase & Co. logo
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$56.00 ➝ $66.00
7/31/2026
Humana Inc. stock logo
HUM
Humana
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$344.00 ➝ $407.00
7/31/2026
Humana Inc. stock logo
HUM
Humana
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetHold$350.00 ➝ $370.00
7/30/2026
Humana Inc. stock logo
HUM
Humana
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold (C) ➝ Hold (C-)
7/30/2026
Humana Inc. stock logo
HUM
Humana
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold ➝ Overweight$463.00
(Data available from 9/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Humana Inc. stock logo
HUM
Humana
$129.66B0.38$24.36 per share16.66$160.53 per share2.53
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
N/AN/AN/AN/A$0.97 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Humana Inc. stock logo
HUM
Humana
$1.19B$10.5738.4026.602.630.88%11.20%3.94%11/6/2026 (Estimated)
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
-$229.97M-$4.19N/AN/AN/AN/A-273.23%-85.48%11/12/2026 (Estimated)

Latest FCM, AFRK, KOD, and HUM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/12/2026Q2 2026
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
-$0.9565-$1.05-$0.0935-$1.05N/AN/A
7/29/2026Q2 2026
Humana Inc. stock logo
HUM
Humana
$7.27$7.61+$0.34$5.73$40.58 billion$40.89 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Humana Inc. stock logo
HUM
Humana
$3.540.87%+7.20%33.49%N/A
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
N/AN/AN/AN/AN/A

Latest FCM, AFRK, KOD, and HUM Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/1/2026
Humana Inc. stock logo
HUM
Humana
quarterly$0.88500.88%10/30/202610/30/202611/27/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Humana Inc. stock logo
HUM
Humana
0.62
1.74
1.74
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
N/A
2.49
2.49

Institutional Ownership

CompanyInstitutional Ownership
Humana Inc. stock logo
HUM
Humana
92.38%
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
89.06%

Insider Ownership

CompanyInsider Ownership
Humana Inc. stock logo
HUM
Humana
0.20%
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
44.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Humana Inc. stock logo
HUM
Humana
67,060120.08 million119.84 millionOptionable
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
9062.85 million34.94 millionOptionable

Recent News About These Companies

Kodiak Sciences (KOD) Races Toward Three Make-Or-Break Trial Verdicts
September 3 at 8:51 AM  |  insidermonkey.comhttps://www.insidermonkey.com/blog/kodiak-sciences-kod-races-toward-three-make-or-break-trial-verdicts-1826878/
Kodiak Sciences Inc. $KOD is Braidwell LP's 9th Largest Position
September 3 at 4:23 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-kodiak-sciences-inc-kod-is-braidwell-lps-9th-largest-position-2026-09-03/
The Manufacturers Life Insurance Company Buys Shares of 114,089 Kodiak Sciences Inc. $KOD
September 1 at 4:48 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-the-manufacturers-life-insurance-company-buys-shares-of-114089-kodiak-sciences-inc-kod-2026-09-01/
Kodiak Sciences Inc. (NASDAQ:KOD) Receives $48.14 Consensus Target Price from Analysts
August 29, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30990999
4,135,355 Shares in Kodiak Sciences Inc. $KOD Bought by BlackRock Inc.
August 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-4135355-shares-in-kodiak-sciences-inc-kod-bought-by-blackrock-inc-2026-08-29/
Jupiter Topco LLC Purchases Shares of 1,526,006 Kodiak Sciences Inc. $KOD
August 28, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-jupiter-topco-llc-purchases-shares-of-1526006-kodiak-sciences-inc-kod-2026-08-28/
Deutsche Bank AG Invests $2.16 Million in Kodiak Sciences Inc. $KOD
August 28, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-deutsche-bank-ag-invests-216-million-in-kodiak-sciences-inc-kod-2026-08-28/
Boone Capital Management LLC Takes Position in Kodiak Sciences Inc. $KOD
August 27, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-boone-capital-management-llc-takes-position-in-kodiak-sciences-inc-kod-2026-08-27/
Algert Global LLC Purchases 38,546 Shares of Kodiak Sciences Inc. $KOD
August 27, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-algert-global-llc-purchases-38546-shares-of-kodiak-sciences-inc-kod-2026-08-27/
Kodiak Sciences Inc. (NASDAQ:KOD) Given Average Rating of "Moderate Buy" by Analysts
August 24, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/kodiak-sciences-inc-nasdaqkod-given-average-rating-of-moderate-buy-by-analysts-2026-08-24/
ICONIQ Capital LLC Invests $49.34 Million in Kodiak Sciences Inc. $KOD
August 24, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-iconiq-capital-llc-invests-4934-million-in-kodiak-sciences-inc-kod-2026-08-24/
Emerald Investment Advisers LLC Makes New Investment in Kodiak Sciences Inc. $KOD
August 23, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-emerald-investment-advisers-llc-makes-new-investment-in-kodiak-sciences-inc-kod-2026-08-23/
Bank of America Corp DE Boosts Stock Holdings in Kodiak Sciences Inc. $KOD
August 23, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-bank-of-america-corp-de-boosts-stock-holdings-in-kodiak-sciences-inc-kod-2026-08-23/
Kodiak Sciences (NASDAQ:KOD) Stock Price Down 4.1% - Time to Sell?
August 21, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/kodiak-sciences-nasdaqkod-stock-price-down-41-time-to-sell-2026-08-21/
Kodiak Sciences Advances ALTO Phase 3 Trial In Diabetic Eye Disease
August 21, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/kodiak-sciences-advances-alto-phase-3-trial-in-diabetic-eye-disease?utm_source=marketbeat.com&utm_medium=referral
Analysts Are Bullish on These Healthcare Stocks: Kodiak Sciences (KOD), ProQR (PRQR)
August 19, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/PRQR/pressreleases/3902970/analysts-are-bullish-on-these-healthcare-stocks-kodiak-sciences-kod-proqr-prqr/
HC Wainwright Lowers Earnings Estimates for Kodiak Sciences
August 19, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/hc-wainwright-lowers-earnings-estimates-for-kodiak-sciences-2026-08-19/
GSA Capital Partners LLP Takes $1.07 Million Position in Kodiak Sciences Inc. $KOD
August 18, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-gsa-capital-partners-llp-takes-107-million-position-in-kodiak-sciences-inc-kod-2026-08-18/
HC Wainwright Reaffirms "Buy" Rating for Kodiak Sciences (NASDAQ:KOD)
August 17, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/hc-wainwright-reaffirms-buy-rating-for-kodiak-sciences-nasdaqkod-2026-08-17/
California State Teachers Retirement System Has $1.12 Million Stock Holdings in Kodiak Sciences Inc. $KOD
August 15, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-california-state-teachers-retirement-system-has-112-million-stock-holdings-in-kodiak-sciences-inc-kod-2026-08-15/
Wall Street Zen Downgrades Kodiak Sciences (NASDAQ:KOD) to Sell
August 15, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/wall-street-zen-downgrades-kodiak-sciences-nasdaqkod-to-sell-2026-08-15/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Humana stock logo

Humana NYSE:HUM

$405.90 +4.93 (+1.23%)
Closing price 09/3/2026 03:58 PM Eastern
Extended Trading
$406.00 +0.10 (+0.02%)
As of 04:01 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Kodiak Sciences stock logo

Kodiak Sciences NASDAQ:KOD

$36.36 -1.14 (-3.04%)
Closing price 09/3/2026 04:00 PM Eastern
Extended Trading
$36.49 +0.13 (+0.35%)
As of 04:09 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as Phase III clinical study for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet biopolymer conjugate for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas